Patents by Inventor Nico Rudolph Niemeijer

Nico Rudolph Niemeijer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OR PREVENTION OF HIV INFECTION
    Publication number: 20230405001
    Abstract: The present invention relates to the treatment or prevention of HIV infection using rilpivirine or a pharmaceutically acceptable salt thereof in the form of micro- or nanoparticles in suspension in combination with a hyaluronidase. The present invention also relates to rilpivirine or a pharmaceutically acceptable salt thereof in the form of micro- or nanoparticles in suspension.
    Type: Application
    Filed: November 17, 2021
    Publication date: December 21, 2023
    Inventors: Steven M. Vesole, Guenter Karl Wilhelm Kraus, Herta Maria Ludovica Crauwels, René Holm, Nico Rudolph Niemeijer, Iwan Caroline F. Vervoort
  • Pharmaceutical Composition Of S-Ketamine Hydrochloride
    Publication number: 20230241009
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 3, 2023
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A. Embrechts, Nico Rudolph Niemeijer
  • Pharmaceutical composition of S-ketamine hydrochloride
    Patent number: 11446260
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 20, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Esther D. G. Basstanie, Johanna Bentz, Roger C. A Embrechts, Nico Rudolph Niemeijer
  • Pharmaceutical Composition Of S-Ketamine Hydrochloride
    Publication number: 20200069612
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: November 6, 2019
    Publication date: March 5, 2020
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A. Embrechts, Nico Rudolph Niemeijer
  • PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
    Publication number: 20190117591
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: December 17, 2018
    Publication date: April 25, 2019
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer
  • PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
    Publication number: 20140275276
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer
  • PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
    Publication number: 20140275277
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer
  • PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
    Publication number: 20140275278
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer
  • PHARMACEUTICAL COMPOSITION OF S-KETAMINE HYDROCHLORIDE
    Publication number: 20140274981
    Abstract: The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Esther D.G. Basstanie, Johanna Bentz, Roger C.A Embrechts, Nico Rudolph Niemeijer